Notably, the positive detection rate of RASSF1A was 61.4% in adenocarcinoma and 54.9% in SCC, which was significantly improved in comparison to other study in histology specimens, 39% in adenocarcinoma and 13% in SCC, respectively (19). The gene discussed is RASSF1; the disease is adenocarcinoma.